FDA “Independent Consultant” Guidance Applies Only To Efficacy Trials
This article was originally published in The Pink Sheet Daily
Executive Summary
Although sponsors may offer a list of independent consultants for biotech clinical trial protocol reviews, the selection rests with FDA. The final guidance allows sponsors to request formal dispute resolution if FDA opts against using a consultant.